Effect of obicetrapib, a potent cholesteryl ester transfer protein inhibitor, on p-tau217 levels in patients with cardiovascular disease
- DOI
- 10.1016/j.tjpad.2025.100394
- Published
- 2026-01
- Container
- The Journal of Prevention of Alzheimer's Disease
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.tjpad.2025.100394,
title = {Effect of obicetrapib, a potent cholesteryl ester transfer protein inhibitor, on p-tau217 levels in patients with cardiovascular disease},
author = {Michael H Davidson and Michael Szarek and Philip Scheltens and Everard Vijverberg and Andrew Hsieh and Marc Ditmarsch and Douglas Kling and Danielle Curcio and Stephen J Nicholls and Kausik K Ray and Jeffrey L. Cummings and John JP Kastelein},
year = {2026},
journal = {The Journal of Prevention of Alzheimer's Disease},
doi = {10.1016/j.tjpad.2025.100394},
url = {https://doi.org/10.1016/j.tjpad.2025.100394}
}RIS
TY - JOUR TI - Effect of obicetrapib, a potent cholesteryl ester transfer protein inhibitor, on p-tau217 levels in patients with cardiovascular disease AU - Michael H Davidson AU - Michael Szarek AU - Philip Scheltens AU - Everard Vijverberg AU - Andrew Hsieh AU - Marc Ditmarsch AU - Douglas Kling AU - Danielle Curcio AU - Stephen J Nicholls AU - Kausik K Ray AU - Jeffrey L. Cummings AU - John JP Kastelein PY - 2026 JO - The Journal of Prevention of Alzheimer's Disease DO - 10.1016/j.tjpad.2025.100394 UR - https://doi.org/10.1016/j.tjpad.2025.100394 ER -
APA
Davidson, M. H., Szarek, M., Scheltens, P., Vijverberg, E., Hsieh, A., Ditmarsch, M., Kling, D., Curcio, D., Nicholls, S. J., Ray, K. K., Cummings, J. L., & Kastelein, J. J. (2026). Effect of obicetrapib, a potent cholesteryl ester transfer protein inhibitor, on p-tau217 levels in patients with cardiovascular disease. The Journal of Prevention of Alzheimer's Disease. https://doi.org/10.1016/j.tjpad.2025.100394
Source records
- crossref · retrieved 2026-09-27T12:08:26.516Z